Zucovog 0.3mg Tablet DT
Marketer
Zuciya Lifesciences
Salt Composition
Voglibose (0.3mg)
Overview Zucovog 0.3mg Tablet DT
Diabeva 0.3mg tablets are indicated for managing type 2 diabetes. This medication assists in regulating postprandial hyperglycemia, employed when dietary modifications and other comparable treatments prove insufficient. Diabeva 0.3mg tablets should be administered immediately prior to meals; dosage frequency is determined individually by your physician to optimize glycemic control. Abrupt cessation is discouraged without medical consultation, as this may precipitate elevated blood glucose and potentially serious complications including renal impairment and vision loss. This medication forms part of a comprehensive treatment plan incorporating a healthful diet, regular physical activity, and weight management, as directed by your doctor. Consistent blood glucose monitoring is crucial during treatment. Commonly reported side effects include abdominal distension, stomach discomfort, anorexia, constipation, and diarrhea. Persistent or bothersome side effects warrant medical attention. While Diabeva 0.3mg tablets themselves do not induce hypoglycemia, concomitant use with other antidiabetic agents (particularly insulin or sulfonylureas) may increase this risk. Hypoglycemic episodes necessitate treatment with pure glucose; sucrose is ineffective. Prior to commencing treatment, inform your physician of any hepatic or renal dysfunction. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., ulcerative colitis or Crohn's disease). Pregnant or lactating individuals should seek medical advice before use. Comprehensive disclosure of all concurrent medications is essential for safety. Excessive alcohol consumption should be avoided due to a heightened hypoglycemia risk.
Uses of Zucovog 0.3mg Tablet DT
Managing Type 2 Diabetes
Major Benefits of Zucovog 0.3mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dissolve the Zucovog 0.3mg Tablet DT in water before consumption. Administer on an empty stomach.
Common Side effects of Zucovog 0.3mg Tablet DT:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Zucovog 0.3mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Zucovog 0.3mg Tablet DT in water before consumption. Administer on an empty stomach.
How Zucovog 0.3mg Tablet DT works:
Zucovog 0.3mg delayed-release tablets are used to manage diabetes. They work by blocking intestinal enzymes that digest complex carbohydrates, thus moderating postprandial blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Combining Zucovog 0.3mg Tablet DT and alcohol is contraindicated.
PregnancySAFE IF PRESCRIBED
The use of Zucovog 0.3mg Tablet DT during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Zucovog 0.3mg Tablet DT appear compatible. Preliminary data from human studies indicate minimal infant risk associated with the medication.
DrivingSAFE
Driving ability is typically unaffected by Zucovog 0.3mg Tablet DT.
KidneyCAUTION
Patients with severe kidney impairment should use Zucovog 0.3mg Tablet DT cautiously. Dosage modification of Zucovog 0.3mg Tablet DT might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Zucovog 0.3mg Tablet DT. Dosage modification of Zucovog 0.3mg Tablet DT might be necessary. Physician consultation is advised.
What if you forget to take Zucovog 0.3mg Tablet DT :
Omit any missed Zucovog 0.3mg Tablet DT dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Zucovog 0.3mg Tablet DT
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |
3,018 People bought this recently